Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants

Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants

Item
http://www.wikidata.org/entity/Q36907355
FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia.Friedreich Ataxia and nephrotic syndrome: a series of two patientsFrataxin levels in peripheral tissue in Friedreich ataxia.Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor.Progression of Friedreich ataxia: quantitative characterization over 5 yearsDegenerative Ataxias: challenges in clinical research.Clinical features of Friedreich's ataxia: classical and atypical phenotypes.Mitochondrial iron-sulfur cluster biogenesis from molecular understanding to clinical disease.Impact of diabetes in the Friedreich ataxia clinical outcome measures study.Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone Deficiency.Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial.
P2860

Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants

Item
http://www.wikidata.org/entity/Q36907355
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Friedreich ataxia clinical out ...... evaluation in 410 participants
@en
type
label
Friedreich ataxia clinical out ...... evaluation in 410 participants
@en
prefLabel
Friedreich ataxia clinical out ...... evaluation in 410 participants
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Friedreich ataxia clinical out ...... evaluation in 410 participants
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932